Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Welch Materials develops and manufactures chromatography consumables such as HPLC columns, SPE columns, GC columns, sample vials, syringe filters, chromatographic media, and protein purification materials. Their products are widely used in biological analysis, pharmaceutical quality control and R&D, food safety testing, chemical analysis, and environmental monitoring[1][2][3][4].
The company has developed over 8,000 column specifications and 335 packing materials. Its proprietary brands include Ultisil™, Welchrom®, Xtimate®, Topsil™, Boltimate™, Blossmate™ series. As of 2024 it sells approximately 70,000 HPLC columns annually to customers in over 94 countries[2]. It has manufacturing facilities in China with global operations including the US and India[5][6].
The company's technologies support analytical chemists across pharma/biotech R&D labs but do not themselves constitute clinical programs or pipelines.
In recent years the company has received industry recognition for innovation in chromatography solutions[8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Welch Materials.